Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2009-11-10
pubmed:databankReference
pubmed:abstractText
To assess the impact of certolizumab pegol (CZP), a novel PEGylated anti-tumor necrosis factor, in combination with methotrexate (MTX) on productivity outside and within the home, and on participation in family, social, and leisure activities in adult patients with rheumatoid arthritis (RA).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0004-3591
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
61
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1592-600
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19877104-Absenteeism, pubmed-meshheading:19877104-Adult, pubmed-meshheading:19877104-Antibodies, Monoclonal, Humanized, pubmed-meshheading:19877104-Antirheumatic Agents, pubmed-meshheading:19877104-Arthritis, Rheumatoid, pubmed-meshheading:19877104-Cost of Illness, pubmed-meshheading:19877104-Drug Therapy, Combination, pubmed-meshheading:19877104-Efficiency, pubmed-meshheading:19877104-Employment, pubmed-meshheading:19877104-Female, pubmed-meshheading:19877104-Humans, pubmed-meshheading:19877104-Immunoglobulin Fab Fragments, pubmed-meshheading:19877104-Leisure Activities, pubmed-meshheading:19877104-Male, pubmed-meshheading:19877104-Methotrexate, pubmed-meshheading:19877104-Middle Aged, pubmed-meshheading:19877104-Polyethylene Glycols, pubmed-meshheading:19877104-Social Behavior
pubmed:year
2009
pubmed:articleTitle
Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis.
pubmed:affiliation
Center for Innovative Therapy, University of California, San Diego, Division of Rheumatology, Allergy and Immunology, 9500 Gilman Drive, Mail Code 0943, La Jolla, CA 92093-0943, USA. akavanaugh@ucsd.edu
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III